We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
- Authors
Taşçı, Elif Şenocak; Oyan, Başak; Sönmez, Özlem; Mutlu, Arda Ulaş; Atcı, Muhammed Mustafa; Sakin, Abdullah; Öner, İrem; Çınkır, Havva Yeşil; Eryılmaz, Melek Karakurt; Çağlayan, Dilek; Balçık, Onur Yazdan; Paksoy, Nail; Karabulut, Senem; Salim, Derya Kıvrak; Bilir, Cemil; Özen, Miraç; Özçelik, Melike; Arıcan, Ali; Akagündüz, Baran; İnal, Ali
- Abstract
This document is a correction notice for an article titled "Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer" published in BMC Cancer. The correction addresses an error in the affiliations of several authors. The original article has been corrected accordingly. The publisher, Springer Nature, remains neutral regarding jurisdictional claims and institutional affiliations. The correction notice is authored by Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, and many others.
- Subjects
COLORECTAL cancer; METASTASIS; REGORAFENIB; CANCER chemotherapy
- Publication
BMC Cancer, 2024, Vol 24, Issue 1, p1
- ISSN
1471-2407
- Publication type
Correction Notice
- DOI
10.1186/s12885-023-11783-5